Enhanced nitric oxide production by macrophages treated with a cell-penetrating peptide conjugate

Bioorg Chem. 2022 Jun:123:105763. doi: 10.1016/j.bioorg.2022.105763. Epub 2022 Mar 26.

Abstract

The SPRY domain-containing SOCS box protein-2 (SPSB2) plays a critical role in the degradation of inducible nitric oxide synthase (iNOS) in macrophages. In this study, we have conjugated a peptide inhibitor of the iNOS-SPSB2 interaction with a cell-penetrating peptide (CPP) for delivery into macrophages, and confirmed its binding to SPSB2. We have assessed the uptake of a fluorophore-tagged analogue by RAW 264.7 and immortalised bone marrow derived macrophage (iBMDM) cell lines, and shown that the CPP-peptide conjugate enhanced NO production. The findings of this study will be useful in further refinement of CPP-peptide conjugates as leads in the development of new antibiotics that target the host innate immune response.

Keywords: Cell-penetrating peptide; Macrophage; Pathogen killing; SPSB; iNOS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell-Penetrating Peptides* / pharmacology
  • Macrophages / metabolism
  • Models, Molecular
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide*

Substances

  • Cell-Penetrating Peptides
  • Nitric Oxide
  • Nitric Oxide Synthase Type II